Healthcare & Biotech
Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could…
- Therapeutics
- Gene Therapy
- CRISPR
- Website
- uncommontherapeutics.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 2-10 people
- Founded
- 2025
- Demo
- Demo only
Similar companies
ParcelBioElevated mRNA for transformative medicines.
LEAH LabsLiving therapies for pets first, and their people next
Rejuvenation Technologies Inc.mRNA therapeutics to extend healthspan entering clinical trials
Kopra BioGenetically engineered viruses that teach your immune system to kill…
Sequence BioDiscovering the true signals of disease to power life-changing drugs.
FinalDoseProgrammable DNA drug destroying all cancers, unlocking 80% of targets
Eris BiotechOur drugs engage the immune system to fight tumors
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration